---
figid: PMC9456504__ijms-23-10104-g001
figtitle: Antimicrobial Peptides in Gynecological Cancers
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9456504
filename: ijms-23-10104-g001.jpg
figlink: /pmc/articles/PMC9456504/figure/ijms-23-10104-f001/
number: F1
caption: 'Tumorigenic and pro-metastatic mechanisms of AMPs on gynecological cancers:
  (1) HBD3 and elafin activate NF-κB pathway [,]; (2) Elafin, S100A7 and SLPI induce
  MEK/ERK pathway [,,,,]; (3) SLPI promotes extracellular matrix remodeling and angiogenesis
  [,]; (4) LL-37 and S100A7 induce epithelial-mesenchymal transition (EMT) [,]; (5)
  HE4 controls cell cycle []; (6) A vicious circle between macrophages and ovarian
  cancer cells by interaction between LL-37 and versican V1 []. MEK, Mitogen-activated
  protein kinases; ERK, Extracellular signal-regulated kinases; RAGE, Receptor for
  advanced glycation end-products; EMT, Epithelial–mesenchymal transition; VDR, vitamin
  D receptor; TLR, Toll-like receptor; MMP, Matrix metalloproteinases; CYP27B1, Cytochrome
  P450 family 27 subfamily B member 1.'
papertitle: Roles of Antimicrobial Peptides in Gynecological Cancers.
reftext: Chongyi Zhao, et al. Int J Mol Sci. 2022 Sep;23(17):10104.
year: '2022'
doi: 10.3390/ijms231710104
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: antimicrobial peptide | gynecological cancers | anticancer peptide | biomarker
  | tumorigenic
automl_pathway: 0.9709739
figid_alias: PMC9456504__F1
figtype: Figure
redirect_from: /figures/PMC9456504__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9456504__ijms-23-10104-g001.html
  '@type': Dataset
  description: 'Tumorigenic and pro-metastatic mechanisms of AMPs on gynecological
    cancers: (1) HBD3 and elafin activate NF-κB pathway [,]; (2) Elafin, S100A7 and
    SLPI induce MEK/ERK pathway [,,,,]; (3) SLPI promotes extracellular matrix remodeling
    and angiogenesis [,]; (4) LL-37 and S100A7 induce epithelial-mesenchymal transition
    (EMT) [,]; (5) HE4 controls cell cycle []; (6) A vicious circle between macrophages
    and ovarian cancer cells by interaction between LL-37 and versican V1 []. MEK,
    Mitogen-activated protein kinases; ERK, Extracellular signal-regulated kinases;
    RAGE, Receptor for advanced glycation end-products; EMT, Epithelial–mesenchymal
    transition; VDR, vitamin D receptor; TLR, Toll-like receptor; MMP, Matrix metalloproteinases;
    CYP27B1, Cytochrome P450 family 27 subfamily B member 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CAMP
  - TLR2
  - DEFB103B
  - DEFB103A
  - NFKBIA
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - MTPN
  - TLR6
  - NFKB1
  - CYP27B1
  - VDR
  - AGER
  - MOK
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - CDH2
  - ITK
  - SLC22A3
  - SLPI
  - MAN2C1
  - MMP9
  - CCND1
  - WFDC2
---
